Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea

被引:7
|
作者
Russo, Chiara [1 ]
Salina, Alessandro [1 ]
Aloi, Concetta [1 ]
Iafusco, Dario [2 ]
Lorini, Renata [1 ]
d'Annunzio, Giuseppe [1 ]
机构
[1] Univ Genoa, Pediat Clin, IRCCS G Gaslini Inst, I-16147 Genoa, Italy
[2] Univ Naples 2, Dept Pediat, Naples, Italy
关键词
Sulfonylureas; Switch to SU; PNDM treatment; KCNJ11; ACTIVATING MUTATIONS; DIABETES-MELLITUS; KIR6.2; INSIGHTS; GENES;
D O I
10.1016/j.diabres.2011.07.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
KCNJ11 gene mutations are related to permanent neonatal diabetes mellitus (PNDM). Glycemic stability minimizes the risk of complications. Sulfonylureas (SU) are the proven best therapeutic option. We report a 18-month follow-up of switching from insulin to SU in a mother and her daughter with PNDM due to KCNJ11 mutation. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E50 / E52
页数:3
相关论文
共 50 条
  • [1] DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea
    Cho, Ja Hyang
    Kang, Eungu
    Lee, Beom Hee
    Kim, Gu-Hwan
    Choi, Jin-Ho
    Yoo, Han-Wook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (06) : 1042 - 1045
  • [2] Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene
    Vendramini, Marcio F.
    Gurgel, Lucimary C.
    Moises, Regina S.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (08) : 682 - 684
  • [3] Successful sulfonylurea treatment of an insulin-naive neonate with diabetes mellitus due to a KCNJ11 mutation
    Wambach, Jennifer A.
    Marshall, Bess A.
    Koster, Joseph C.
    White, Neil H.
    Nichols, Colin G.
    PEDIATRIC DIABETES, 2010, 11 (04) : 286 - 288
  • [4] Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene
    Al-Mahdi, Maria
    Al Mutair, Angham
    Al Balwi, Mohammed
    Hussain, Khalid
    ANNALS OF SAUDI MEDICINE, 2010, 30 (02) : 162 - 164
  • [5] Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2-initial and long-term response to sulfonylurea therapy
    Wagner, Verena M.
    Kremke, Britta
    Hiort, Olaf
    Flanagan, Sarah E.
    Pearson, Ewan R.
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (03) : 359 - 361
  • [6] Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2—initial and long-term response to sulfonylurea therapy
    Verena M. Wagner
    Britta Kremke
    Olaf Hiort
    Sarah E. Flanagan
    Ewan R. Pearson
    European Journal of Pediatrics, 2009, 168 : 359 - 361
  • [7] Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea
    Lau, Eva
    Correia, Cintia
    Freitas, Paula
    Nogueira, Cladia
    Costa, Maria
    Saavedra, Ana
    Costa, Carla
    Carvalho, Davide
    Fontoura, Manuel
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2015, 59 (06): : 559 - 561
  • [8] Successful transition from insulin to sulfonylurea for a 26 year old female with neonatal diabetes secondary to KCNJ11 gene mutation
    Ali, S.
    Garrahy, A.
    Byrne, M. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S355 - S355
  • [9] Successful transition from insulin to sulfonylurea treatment in an adult with permanent neonatal diabetes mellitus with a KCNJ11 mutation: A case report
    O'Brien, C.
    Bell, M.
    Griffin, T.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 4) : 105 - 105
  • [10] Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11
    Yoon, Jong Seo
    Park, Kyu Jung
    Sohn, Young Bae
    Lee, Hae Sang
    Hwang, Jin Soon
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 23 (03) : 154 - 157